首页 › 基金 › Logos Global Management LP › DYN

Logos Global Management LP 对 DYN 的持仓历史

DYNE THERAPEUTICS INC · 医疗保健

Logos Global Management LP 在 Q2 2026 的 13F 申报中披露持有 DYN(DYNE THERAPEUTICS INC)2,550,000 股,市值约 US$56.6M,约占其申报组合的 2.44%,在其申报持仓中市值排名第 14 位。 Logos Global Management LP 最近 12 个申报季度中有 12 个季度披露了 DYN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)2.55M 股
申报持仓市值$56.64M
组合权重2.44%
首次申报Q3 2023
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Logos Global Management LP 对 DYN 的持仓演变

Logos Global Management LP 于 Q3 2023 首次披露 DYN 持仓:2,180,000 股(约 US$19.5M)。 该持仓在 Q2 2026 达到峰值 2,550,000 股,市值约 US$56.6M。 在 12 次申报中,Logos Global Management LP 6 次增持、5 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 2,550,000 股、市值约 US$56.6M,环比增持 1,150,000 股。。 持仓曾出现大幅变动:Q2 2024 减持约 85% (随后一个季度股价上涨 2%)、Q4 2024 增持约 181% (随后一个季度股价下跌 56%)、Q2 2025 增持约 280% (随后一个季度股价上涨 33%)。

逐季持仓明细

季度股数金额变化
Q3 2023 2.18M $19.53M 新进
Q4 2023 1.88M $25.00M 减持
Q1 2024 1.73M $49.11M 减持
Q2 2024 265.00K $9.35M 减持
Q3 2024 160.00K $5.75M 减持
Q4 2024 450.00K $10.60M 增持
Q1 2025 500.00K $5.23M 增持
Q2 2025 1.90M $18.09M 增持
Q3 2025 2.40M $30.36M 增持
Q4 2025 1.25M $24.45M 减持
Q1 2026 1.40M $25.38M 增持
Q2 2026 2.55M $56.64M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 DYN 与 13F 数据

DYN(DYNE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 DYN,申报仓位最大的包括:Atlas Venture Life Science Advisors, LLC (US$151.0M), TCG Crossover Management, LLC (US$102.5M), FCPM III SERVICES B.V. (US$85.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 DYN 的基金

查看 DYN 的全部基金持有人 →

常见问题

How long has Logos Global Management LP held DYN?

Logos Global Management LP has disclosed DYN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Logos Global Management LP's current position in DYN?

As of Q2 2026, Logos Global Management LP holds 2.55M shares of DYN (DYNE THERAPEUTICS INC), valued at $56.64M, representing 2.44% of its reported portfolio and ranking #14.

Has Logos Global Management LP been buying or selling DYN?

In the latest 13F filing (Q2 2026), Logos Global Management LP increased its position in DYN. The position peaked in Q2 2026 at 2.55M shares.

Which other funds hold DYN?

Other major institutional holders of DYN include Atlas Venture Life Science Advisors, LLC, TCG Crossover Management, LLC, FCPM III SERVICES B.V., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.